Repligen (RGEN) Net Cash Flow (QoQ) (2010 - 2026)
Powered by 
Analysis
Repligen (RGEN) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.45% |
| Mar 31, 2026 | 110.26% |
| Dec 31, 2025 | -556.23% |
| Sep 30, 2025 | 276.70% |
| Jun 30, 2025 | 116.59% |
| Mar 31, 2025 | -165.70% |
| Dec 31, 2024 | 7.67% |
| Sep 30, 2024 | -190.10% |
| Jun 30, 2024 | 6.01% |
| Mar 31, 2024 | -78.50% |
| Dec 31, 2023 | 328.82% |
| Sep 30, 2023 | -67.19% |
| Jun 30, 2023 | 1,253.74% |
| Mar 31, 2023 | 86.86% |
| Dec 31, 2022 | -301.32% |
| Sep 30, 2022 | -186.45% |
| Jun 30, 2022 | 200.50% |
| Mar 31, 2022 | -37.80% |
| Dec 31, 2021 | 88.74% |
| Sep 30, 2021 | -630.58% |